Article Versions Notes

Toscano A, Cinquegrani M, Scuruchi M, Di Pino A, Piro S, Ferrara V, Morace C, Lo Gullo A, Imbalzano E, Purrello F, et al. PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy. Biomolecules. 2022; 12(4):562. https://doi.org/10.3390/biom12040562

Toscano, Arianna, Maria Cinquegrani, Michele Scuruchi, Antonino Di Pino, Salvatore Piro, Viviana Ferrara, Carmela Morace, Alberto Lo Gullo, Egidio Imbalzano, Francesco Purrello, and et al. 2022. "PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy" Biomolecules 12, no. 4: 562. https://doi.org/10.3390/biom12040562

Toscano, A., Cinquegrani, M., Scuruchi, M., Di Pino, A., Piro, S., Ferrara, V., Morace, C., Lo Gullo, A., Imbalzano, E., Purrello, F., Squadrito, G., Scicali, R., & Mandraffino, G. (2022). PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy. Biomolecules, 12(4), 562. https://doi.org/10.3390/biom12040562